Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

As part of their research, scientists developed an algorithm that calculates a person's risk of future bowel cancer based on ...

The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

The Myeloid Genomics Test covers 79 genes, including those linked to inherited risks, to detect key genetic changes and ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.